Abstract
Paediatric inflammatory multisystem syndrome associated with severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) infection (PIMS-TS) is defined as ‘a child presenting with persistent fever, inflammation and evidence of single or multi-organ dysfunction with additional features which include a rash’.1 The World Health Organisation’s (WHO) definition further includes a ‘rash or bilateral non-purulent conjunctivitis or muco-cutaneous inflammation signs’.2 Previously reported mucocutaneous manifestations (MCM) in PIMS-TS have been vague. This study aimed to delineate the MCM of children presenting with PIMS-TS in more detail.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
